Bobby Thompson
About Bobby Thompson
Bobby Thompson is a Sr. Cell Therapy Account Specialist at Kite Pharma, with extensive experience in oncology and hematology sales across various companies. He has held positions at Karyopharm Therapeutics, Pharmacyclics, Medivation, Ortho Biotech, Merck, and Janssen Pharmaceuticals, and he holds a Bachelor of Business Administration from Texas A&M University.
Current Role at Kite Pharma
Bobby Thompson currently serves as a Senior Cell Therapy Account Specialist at Kite Pharma. He has held this position since 2021, contributing to the company's focus on innovative cell therapies. His role involves engaging with healthcare professionals and stakeholders to promote Kite Pharma's products and services in the cell therapy sector.
Previous Experience in Hematology and Oncology
Before joining Kite Pharma, Bobby Thompson worked at Karyopharm Therapeutics Inc. as a Hematology Oncology Specialist from 2019 to 2021. He also held the position of Hematology Clinical Account Specialist at Pharmacyclics, an AbbVie Company, from 2018 to 2019. His experience in these roles provided him with a strong foundation in hematology and oncology sales.
Sales Experience in Oncology
Bobby Thompson has extensive experience in oncology sales, having worked as a Senior Sales Specialist at Medivation from 2014 to 2018. His career in oncology began earlier, with roles at Ortho Biotech from 2002 to 2008 and at The Janssen Pharmaceutical Companies of Johnson & Johnson from 2008 to 2014. This background has equipped him with a deep understanding of the oncology market.
Educational Background in Business Administration
Bobby Thompson studied at Texas A&M University, where he earned a Bachelor of Business Administration (B.B.A.) degree with a focus on Accounting. His education spanned from 1988 to 1992, providing him with essential skills in business and finance that support his career in pharmaceutical sales.
Early Career in Pharmaceutical Sales
Bobby Thompson began his career in pharmaceutical sales at Merck, where he worked from 1997 to 2000. He later gained additional experience at Ortho Biotech, where he focused on oncology sales from 2002 to 2008. These early roles laid the groundwork for his subsequent positions in the industry.